Literature DB >> 18755621

Salivary levels of cortisol and chromogranin A in patients with dry mouth compared with age-matched controls.

Chieko Shigeyama1, Toshihiro Ansai, Shuji Awano, Inho Soh, Akihiro Yoshida, Tomoko Hamasaki, Yasuaki Kakinoki, Kazuhiro Tominaga, Tetsu Takahashi, Tadamichi Takehara.   

Abstract

OBJECTIVE: To evaluate the salivary levels of cortisol and chromogranin A (CgA) in patients with dry mouth (perceived xerostomia and hyposalivation) compared with age-matched controls. STUDY
DESIGN: We studied 174 subjects, including those with dry mouth, classified into 2 subgroups based on perceived xerostomia and salivation, and those without (control subjects). The control subjects were patients at the same hospital and healthy volunteers. Cortisol and CgA levels in stimulated whole saliva were measured using ELISA kits.
RESULTS: All subjects with dry mouth had significantly higher cortisol and CgA levels than the control subjects. The statistical associations remained significant when they were divided into the 2 subgroups, although somewhat weaker associations were observed. The influences of xerogenic drugs were found to be minimal on salivary flow rate and levels of cortisol and CgA.
CONCLUSIONS: We found significant associations between salivary cortisol and CgA levels and symptoms of oral dryness and reduced salivary flow.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18755621     DOI: 10.1016/j.tripleo.2008.07.005

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  8 in total

1.  Salivary function impairment in type 2 Diabetes patients associated with concentration and genetic polymorphisms of chromogranin A.

Authors:  Evelyn Mikaela Kogawa; Daniela Corrêa Grisi; Denise Pinheiro Falcão; Ingrid Aquino Amorim; Taia Maria Berto Rezende; Izabel Cristina Rodrigues da Silva; Osmar Nascimento Silva; Octávio Luiz Franco; Rivadávio Fernandes Batista de Amorim
Journal:  Clin Oral Investig       Date:  2016-01-11       Impact factor: 3.573

2.  Chromogranin A detection in saliva of type 2 diabetes patients.

Authors:  Martine Soell; Ahmed Feki; Matthias Hannig; Hidehiko Sano; Michel Pinget; Denis Selimovic
Journal:  Bosn J Basic Med Sci       Date:  2010-02       Impact factor: 3.363

3.  Investigation of the levels of different salivary stress markers in chronic periodontitis patients.

Authors:  Hakan Develioglu; Saygin Korkmaz; Serkan Dundar; Ulrich Schlagenhauf
Journal:  J Oral Biol Craniofac Res       Date:  2020-08-12

4.  Nesfatin-1 and ghrelin levels in serum and saliva of epileptic patients: hormonal changes can have a major effect on seizure disorders.

Authors:  Suleyman Aydin; Ersel Dag; Yusuf Ozkan; Fazilet Erman; Adile Ferda Dagli; Nermin Kilic; Ibrahim Sahin; Fikret Karatas; Tahir Yoldas; Abdullah Onder Barim; Yalcin Kendir
Journal:  Mol Cell Biochem       Date:  2009-03-05       Impact factor: 3.396

5.  "Dry mouth" and "Flammer" syndromes-neglected risks in adolescents and new concepts by predictive, preventive and personalised approach.

Authors:  Analtoly Kunin; Jiri Polivka; Natalia Moiseeva; Olga Golubnitschaja
Journal:  EPMA J       Date:  2018-08-02       Impact factor: 6.543

6.  Acute short-term mental stress does not influence salivary flow rate dynamics.

Authors:  Ella A Naumova; Tudor Sandulescu; Philipp Al Khatib; Michael Thie; Wing-Kee Lee; Stefan Zimmer; Wolfgang H Arnold
Journal:  PLoS One       Date:  2012-12-13       Impact factor: 3.240

7.  Determining the relationship among stress, xerostomia, salivary flow rate, and the quality of life of undergraduate dental students.

Authors:  Saira Atif; Sofia A Syed; Ume R Sherazi; Sadia Rana
Journal:  J Taibah Univ Med Sci       Date:  2020-11-24

8.  Assessment of Salivary Flow and Anxiety in Patients Rehabilitated with Implant-Supported Prostheses.

Authors:  Agda Marobo Andreotti; Marcelo Coelho Goiato; Mariana Vilela Sônego; Emily Vivianne Freitas da Silva; Daniela Micheline Dos Santos
Journal:  Contemp Clin Dent       Date:  2019 Jan-Mar
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.